In August of 2001, President Bush announced his decision to limit federal funding of stem cell research to already established lines of embryonic stem cells, while forbidding funding for any research that required the destruction of additional human embryos. But his decision ended neither stem cell research nor the debate over the ethics of such research. How do we weigh the medical benefits of this research against the destruction of embryos? Where do we draw the line on research using human embryos and are we on a slippery slope toward even more controversial research?
Be careful when one uses the superlative case—best, most, -est, etc.—or evokes end-of-the-world imagery...
The Hoover Institution hosted its annual Board of Overseers’ summer meeting during July 9–11, 2013.
The program began on Tuesday evening with before-dinner remarks by Paul D. Clement, a partner at Bancroft PLLC. Clement served as the forty-third solicitor general of the United States from June 2005 until June 2008. He has argued more than sixty-five cases before the US Supreme Court. During Clement’s speech, titled “Federalism in the Roberts Court,” he talked about the revitalization of federalism in the Rehnquist court “imposing some limits on the federal government’s power vis-a-vis the states.”
Peter Berkowitz on Human Cloning and Human Dignity: An Ethical Inquiry by the President’s Council on Bioethics
The News article by Catherine Shaffer in the December issue1 entitled “FDA recruits prominent critics” contends that the “the general response” to the appointment of anti-industry zealot Peter Lurie of Public Citizen “is positive, even among those who don't necessarily agree with Lurie's positions.”. . .
Who’s winning on the Internet, the Left or the Right?...
Thomas Sowell introduces his new book, Intellectuals and Society, and expounds on what he calls “the fatal misstep of intellectuals.” . . .
Matt Ridley, author of The Rational Optimist, insists that we humans must face the truth about ourselves—no matter how good it might be. An interview with Peter Robinson.